Baseline variation in use of VA/DOD clinical practice guideline recommended opioid prescribing practices across VA health care systems

Clinical Journal of Pain

Volumn 31, Issue 9, 2015, Pages 803-812

  Buscaglia, Alexander C ^a   Paik, Meenah C ^a   Lewis, Eleanor ^a   Trafton, Jodie A ^a,b,c  

^a VA Center for Innovation to Implementation   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Adherence; Guideline; Opioid; Prescribing; VA; Veteran's Hospital

Indexed keywords

LONG ACTING DRUG; OPIATE; SEDATIVE AGENT; SHORT ACTING DRUG; TRAMADOL;

ARTICLE; CHRONIC PAIN; CLINICAL PRACTICE; DRUG DEPENDENCE; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; UNITED STATES; VETERANS HEALTH;

EID: 84995791285     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000160     Document Type: Article

References (26)

1. Kleinrock M. The use of medicines in the United States: review of 2010. 2011. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/ Static%20File/IHII_UseOfMed_report.pdf. Accessed May 31, 2013.
2. Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011;72:589-592.
3. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346-1347.
4. VA/DoD Opioid Therapy for Chronic Pain Working Group. The Management of Opioid Therapy for Chronic Pain. Washington, DC: The Office of Quality and Performance, VA and Quality Management Directorate, US Army MED-COM; 2010.
5. Chou R. What we still don't know about treating chronic noncancer pain with opioids. Can Med Assoc J. 2010;182: 881-882.
6. McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the US. J Pain. 2012;13:988-996.
7. Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145:287-293.
8. Edlund MJ, Martin BC, Devries A, et al. Trends in use of opioids for chronic non-cancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2011;26:1-8.
9. Starrels JL, Becker WC, Weiner MG, et al. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011;26: 958-964.
10. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J Gen Intern Med. 2011;26:965-971.
11. Victor TW, Alvarez NA, Gould E. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice. J Pain. 2009;10:1051-1057.
12. Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22: 1859-1865.
13. Krebs EE, Ramsey DC, Miloshoff JM, et al. Primary care monitoring of long-term opioid therapy among veterans with chronic pain. Pain Med. 2011;12:740-746.
14. Gupta A, Patton C, Diskina D, et al. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Pain Phys. 2011;14:383-389.
15. Stetler CB, Mittman BS, Francis J. Overview of the VA quality enhancement research initiative (QUERI) and QUERI theme articles: QUERI series. Implement Sci. 2008;3:8.
16. Trafton J, Martins S, Michel M, et al. Evaluation of the acceptability and usability of a decision support system to encourage safe and effective use of opioid therapy for chronic, noncancer pain by primary care providers. Pain Med. 2010;11:575-585.
17. Midboe AM, Lewis ET, Paik MC, et al. Measurement of adherence to clinical practice guidelines for opioid therapy for chronic pain. Transl Behav Med. 2012;2:57-64.
18. Van Middelkoop M, Rubinstein SM, Kuijpers T, et al. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain. Eur Spine J. 2011;20:19-39.
19. Manchikanti L, Vallejo R, Manchikanti KN, et al. Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Phys. 2011;14:E133-E156.
20. Pergolizzi J, Pappagallo M, Stauffer J, et al. The role of urine drug testing for patients on opioid therapy. Pain Pract. 2010;10:497-507.
21. Congressional Testimony of Dr. Robert L. Jesse to the House Committee on Veterans Affairs. 2013. Available at: http://veterans.house.gov/witness-testimony/robert-ljesse-md. Accessed March 5, 2014.
22. Deyo RA, Smith DHM, Johnson ES, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med. 2011;24:717-727.
23. Coben JH, Davis SM, Furbee PM, et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38:517-524.
24. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013;131:263-270.
25. Saunders KW, Von Korff M, Campbell CI, et al. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012; 13:266-275.
26. US Food and Drug Administration. Acetaminophen Prescription Combination Drug Products with more than 325mg: FDA Statement-Recommendation to Discontinue Prescribing and Dispensing. 2014. Available at: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhuman medicalproducts/ucm381650.htm. Accessed March 7, 2014.